Fate Therapeutics, Inc.

8-K Director or officer change; Shareholder vote results Jun 15, 2026 8-K Other events Jun 4, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Results of operations (earnings release) May 13, 2026 10-K Fiscal year ended 2025-12-31 Feb 26, 2026 8-K Results of operations (earnings release) Feb 26, 2026 10-Q Quarter ended 2025-09-30 Nov 13, 2025 8-K Results of operations (earnings release) Nov 13, 2025 8-K Regulation FD disclosure; Other events Oct 27, 2025 8-K Director or officer change; Regulation FD disclosure Oct 14, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release); Exit or disposal costs Aug 12, 2025 8-K/A Shareholder vote results Jun 17, 2025 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure May 30, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 5, 2025 8-K Results of operations (earnings release) Mar 5, 2025 8-K Director or officer change Jan 6, 2025 8-K Director or officer change; Regulation FD disclosure Nov 29, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement; Director or officer change Aug 30, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Results of operations (earnings release) Aug 13, 2024 8-K Director or officer change; Regulation FD disclosure Jul 31, 2024 8-K Amended charter or bylaws Jun 10, 2024 8-K Director or officer change; Shareholder vote results Jun 7, 2024 8-K Director or officer change May 31, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 8-K Results of operations (earnings release) May 9, 2024 8-K Regulation FD disclosure; Other events May 9, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Mar 21, 2024 10-K Fiscal year ended 2023-12-31 Feb 26, 2024 8-K Results of operations (earnings release) Feb 26, 2024 8-K Entered a material agreement; Terminated a material agreement Nov 8, 2023 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Other events Sep 1, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023